'Break up' with J&J? Some are ready to try Pfizer or Moderna as FDA panel considers boosters.
An FDA committee is meeting Friday to determine if a second shot is needed for people who first received the Johnson & Johnson COVID-19 vaccine.
'Break up' with J&J? Some are ready to try Pfizer or Moderna as FDA panel considers boosters.
USATODAY.com
0 shares
2 views
You might like
Related news coverage
CDC Advisory Panel Meets To Discuss Moderna, J&J Booster Shots
Newsy
Watch VideoAn advisory committee for the CDC will meet to discuss COVID-19 booster shots for Moderna and Johnson and..
Advertisement
More coverage
The Science Of Mixing COVID-19 Boosters
Newsy
Watch VideoAn early NIH study of different booster combos show an extra dose of any COVID vaccine increases virus-fighting..
